The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease
Abstract
Dysfunction of cholinergic basal forebrain (CBF) neurons of the nucleus basalis (NB) is a cardinal feature of Alzheimer's disease (AD) and correlates with cognitive decline. Survival of CBF neurons depends upon binding of nerve growth factor (NGF) with high‐affinity (trkA) and low‐affinity (p75 NTR) neurotrophin receptors produced within CBF neurons. Since trkA and p75 NTR protein levels are reduced within CBF neurons of people with mild cognitive impairment (MCI) and mild AD, trkA and/or p75 NTR gene expression deficits may drive NB degeneration. Using single cell expression profiling methods coupled with custom‐designed cDNA arrays and validation with real‐time quantitative PCR (qPCR) and in situ hybridization, individual cholinergic NB neurons displayed a significant down regulation of trkA, trkB, and trkC expression during the progression of AD. An intermediate reduction was observed in MCI, with the greatest decrement in mild to moderate AD as compared to controls. Importantly, trk down regulation is associated with cognitive decline measured by the Global Cognitive Score (GCS) and the Mini‐Mental State Examination (MMSE). In contrast, there is a lack of regulation of p75 NTR expression. Thus, trk defects may be a molecular marker for the transition from no cognitive impairment (NCI) to MCI, and from MCI to frank AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Mild cognitive impairment as a diagnostic entity
Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864
The cholinergic hypothesis of geriatric memory dysfunction
Bartus, R. T., Dean, R. L., Beer, B., & Lippa, A. S. (1982) · Science · doi:10.1126/science.7046051 · Cited by 5,545
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L. ‐., Nordberg, A., Bäckman, L., Albert, M., Almkvist, O., et al. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01380.x · Cited by 4,946
Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain
Whitehouse, P., Price, D., Struble, R., Clark, A., Coyle, J., & DeLong, M. R. (1982) · Science · doi:10.1126/science.7058341 · Cited by 3,627
Mesulam, M. ‐., Mufson, E. J., Levey, A. I., & Wainer, B. H. (1983) · Journal of Comparative Neurology · doi:10.1002/cne.902140206 · Cited by 1,962
Self-citationNeurotrophin signal transduction in the nervous system
Kaplan, D. R., & Miller, F. D. (2000) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00092-1 · Cited by 1,944
HYMAN, B. T., & TROJANOWSKI, J. Q. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199710000-00002 · Cited by 1,542
Nerve Growth Factor Signaling, Neuroprotection, and Neural Repair
Sofroniew, M. V., Howe, C. L., & Mobley, W. C. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1217 · Cited by 1,284
A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease
Tuszynski, M. H., Thal, L., Pay, M., Salmon, D. P., U, H. S., Bakay, R., Patel, P., Blesch, A., Vahlsing, H. L., Ho, G., et al. (2005) · Nature Medicine · doi:10.1038/nm1239 · Cited by 1,050
Self-citationNatural history of mild cognitive impairment in older persons
Bennett, D. A., Wilson, R. S., Schneider, J. A., Evans, D. A., Beckett, L. A., Aggarwal, N. T., Barnes, L. L., Fox, J. H., & Bach, J. (2002) · Neurology · doi:10.1212/wnl.59.2.198 · Cited by 1,037 · cited 6×
“Additional sections were stained for Lewy bodies using commercially available antibodies directed against ubiquitin and alpha-synuclein (Mufson et al. 2000, 2002; Bennett et al. 2002).”
BackgroundMethodInfluentialExpression and structure of the human NGF receptor
Johnson, D., Lanahan, A., Buck, C. R., Sehgal, A., Morgan, C., Mercer, E., Bothwell, M., & Chao, M. (1986) · Cell · doi:10.1016/0092-8674(86)90619-7 · Cited by 963
Sortilin is essential for proNGF-induced neuronal cell death
Nykjaer, A., Lee, R., Teng, K. K., Jansen, P., Madsen, P., Nielsen, M. S., Jacobsen, C., Kliemannel, M., Schwarz, E., Willnow, T. E., et al. (2004) · Nature · doi:10.1038/nature02319 · Cited by 962
Peng, S., Wuu, J., Mufson, E. J., & Fahnestock, M. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03135.x · Cited by 691
Self-citationDeKosky, S. T., Ikonomovic, M. D., Styren, S. D., Beckett, L., Wisniewski, S., Bennett, D. A., Cochran, E. J., Kordower, J. H., & Mufson, E. J. (2002) · Annals of Neurology · doi:10.1002/ana.10069 · Cited by 686 · cited 1×
“…impaired neuropsychological test scores who were not found to have dementia by the examining neurologist (Mufson et al. 2000; Bennett et al. 2002; DeKosky et al. 2002), similar to the criteria used by independent experts in the field to describe subjects who are not cognitively normal but do not…”
MethodSelf-citationBierer, L. M., Haroutunian, V., Gabriel, S., Knott, P. J., Carlin, L. S., Purohit, D. P., Perl, D. P., Schmeidler, J., Kanof, P., & Davis, K. L. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64020749.x · Cited by 580
Wilcock, G. K., Esiri, M. M., Bowen, D. M., & Smith, C. C. T. (1982) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(82)90045-4 · Cited by 553
Neuronal cell death is preceded by cell cycle events at all stages of Alzheimer’s disease
Yang, Y., Mufson, E. J., & Herrup, K. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-07-02557.2003 · Cited by 483 · cited 2×
“p75-mediated apoptosis involves the activation of cell cycle regulatory molecules, and a link between aberrant cell cycle re-entry of post-mitotic neurons and apoptosis has been established in CBF neurons in MCI and early AD (Yang et al. 2003).”
BackgroundSelf-citationCompetitive Signaling Between TrkA and p75 Nerve Growth Factor Receptors Determines Cell Survival
Yoon, S. O., Casaccia-Bonnefil, P., Carter, B., & Chao, M. V. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-09-03273.1998 · Cited by 482
Shelton, D., Sutherland, J., Gripp, J., Camerato, T., Armanini, M., Phillips, H., Carroll, K., Spencer, S., & Levinson, A. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-01-00477.1995 · Cited by 399
Holtzman, D. M., Li, Y., Parada, L. F., Kinsman, S., Chen, C.-K., Valletta, J. S., Zhou, J., Long, J. B., & Mobley, W. C. (1992) · Neuron · doi:10.1016/0896-6273(92)90184-f · Cited by 365
Cognitive functions of the basal forebrain
Baxter, M. G., & Chiba, A. A. (1999) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(99)80024-5 · Cited by 351
Cooper, J. D., Salehi, A., Delcroix, J.-D., Howe, C. L., Belichenko, P. V., Chua-Couzens, J., Kilbridge, J. F., Carlson, E. J., Epstein, C. J., & Mobley, W. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181219298 · Cited by 336 · cited 1×
“Interestingly, deficits in trkA and retrograde transport of NGF to CBF consumer neurons occurs in end stage AD (Mufson et al. 1997), in a segmental trisomy mouse model of Down’s syndrome (Cooper et al. 2001), and in aged rats with cognitive impairment (Cooper et al. 1994; De Lacalle et al. 1996).”
BackgroundExpression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons
Ginsberg, S. D., Hemby, S. E., Lee, V. M.-Y., Eberwine, J. H., & Trojanowski, J. Q. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200007)48:1<77::aid-ana12>3.0.co;2-a · Cited by 315
Self-citationHuman cholinergic basal forebrain: chemoanatomy and neurologic dysfunction
Mufson, E. J., Ginsberg, S. D., Ikonomovic, M. D., & DeKosky, S. T. (2003) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(03)00068-1 · Cited by 295
Self-citationMufson, E. J., Bothwell, M., & Kordower, J. H. (1989) · Experimental Neurology · doi:10.1016/0014-4886(89)90124-6 · Cited by 279
Self-citationAlzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice
Capsoni, S., Ugolini, G., Comparini, A., Ruberti, F., Berardi, N., & Cattaneo, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.12.6826 · Cited by 277
Expression of NGF receptor in the developing and adult primate central nervous system
Schatteman, G., Gibbs, L., Lanahan, A., Claude, P., & Bothwell, M. (1988) · The Journal of Neuroscience · doi:10.1523/jneurosci.08-03-00860.1988 · Cited by 251
Mufson, E. J., Bothwell, M., Hersh, L. B., & Kordower, J. H. (1989) · Journal of Comparative Neurology · doi:10.1002/cne.902850204 · Cited by 245
Self-citationMufson, E. J., Ma, S. Y., Cochran, E. J., Bennett, D. A., Beckett, L., Jaffar, S., Saragovi, H. U., & Kordower, J. H. (2000) · The Journal of Comparative Neurology · doi:10.1002/1096-9861(20001106)427:1<19::aid-cne2>3.0.co;2-a · Cited by 243
Self-citationGilmor, M. L., Erickson, J. D., Varoqui, H., Hersh, L. B., Bennett, D. A., Cochran, E. J., Mufson, E. J., & Levey, A. I. (1999) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19990906)411:4<693::aid-cne13>3.0.co;2-d · Cited by 239
Self-citationIncreased proNGF Levels in Subjects with Mild Cognitive Impairment and Mild Alzheimer Disease
Peng, S., Wuu, J., Mufson, E. J., & Fahnestock, M. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.6.641 · Cited by 236
Self-citationCounts, S. E., & Mufson, E. J. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.4.263 · Cited by 222
Self-citationNeurotrophins and their receptors: signaling trios in complex biological systems
Teng, K. K., & Hempstead, B. L. (2004) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-003-3099-3 · Cited by 222
Li, Y., Holtzman, D., Kromer, L., Kaplan, D., Chua-Couzens, J., Clary, D., Knusel, B., & Mobley, W. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-04-02888.1995 · Cited by 220
Ruberti, F., Capsoni, S., Comparini, A., Di Daniel, E., Franzot, J., Gonfloni, S., Rossi, G., Berardi, N., & Cattaneo, A. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-07-02589.2000 · Cited by 212
Cortical neurons express nerve growth factor receptors in advanced age and Alzheimer disease.
Mufson, E. J., & Kordower, J. H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.2.569 · Cited by 190
Self-citationSequestration of RNA in Alzheimer's disease neurofibrillary tangles and senile plaques
Ginsberg, S. D., Crino, P. B., Lee, V. M. ‐., Eberwine, J. H., & Trojanowski, J. Q. (1997) · Annals of Neurology · doi:10.1002/ana.410410211 · Cited by 189
Self-citationReduction in p140-TrkA Receptor Protein within the Nucleus Basalis and Cortex in Alzheimer's Disease
Mufson, E. J., Lavine, N., Jaffar, S., Kordower, J. H., Quirion, R., & Saragovi, H. U. (1997) · Experimental Neurology · doi:10.1006/exnr.1997.6504 · Cited by 187
Self-citationSignaling endosome hypothesis: A cellular mechanism for long distance communication
Howe, C. L., & Mobley, W. C. (2004) · Journal of Neurobiology · doi:10.1002/neu.10323 · Cited by 185
Reduction of cortical TrkA but not p75NTR protein in early‐stage Alzheimer's disease
Counts, S. E., Nadeem, M., Wuu, J., Ginsberg, S. D., Saragovi, H. U., & Mufson, E. J. (2004) · Annals of Neurology · doi:10.1002/ana.20233 · Cited by 183
Self-citationFahnestock, M., Yu, G., Michalski, B., Mathew, S., Colquhoun, A., Ross, G. M., & Coughlin, M. D. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02360.x · Cited by 171
Pedraza, C. E., Podlesniy, P., Vidal, N., Arévalo, J. C., Lee, R., Hempstead, B., Ferrer, I., Iglesias, M., & Espinet, C. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62275-4 · Cited by 164
Naumann, T., Casademunt, E., Hollerbach, E., Hofmann, J., Dechant, G., Frotscher, M., & Barde, Y.-A. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02409.2002 · Cited by 162
NGF receptor gene expression is decreased in the nucleus basalis in Alzheimer's disease
Higgins, G. A., & Mufson, E. J. (1989) · Experimental Neurology · doi:10.1016/0014-4886(89)90155-6 · Cited by 158
Self-citationRNA sequestration to pathological lesions of neurodegenerative diseases
Ginsberg, S. D., Galvin, J. E., Chiu, T.-L. S., Lee, V. M. ‐., Masliah, E., & Trojanowski, J. Q. (1998) · Acta Neuropathologica · doi:10.1007/s004010050923 · Cited by 149
Self-citationGene Expression Profiles of Cholinergic Nucleus Basalis Neurons in Alzheimer's Disease
Mufson, E. J., Counts, S., & Ginsberg, S. D. (2002) · Neurochemical Research · doi:10.1023/a:1020952704398 · Cited by 147
Self-citationGrowth-factor gene therapy for neurodegenerative disorders
Tuszynski, M. H. (2002) · The Lancet Neurology · doi:10.1016/s1474-4422(02)00006-6 · Cited by 139
Salehi, A., Verhaagen, J., Dijkhuizen, P. A., & Swaab, D. F. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00273-4 · Cited by 137
Cooper, J. D., Lindholm, D., & Sofroniew, M. V. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90462-6 · Cited by 116
Decreased trkA gene expression within basal forebrain neurons in Alzheimer's disease
Mufson, E., Li, J.-M., Sobreviela, T., & Kordower, J. (1996) · NeuroReport · doi:10.1097/00001756-199612200-00006 · Cited by 100
Self-citationRNA amplification strategies for small sample populations
Ginsberg, S. D. (2005) · Methods · doi:10.1016/j.ymeth.2005.09.003 · Cited by 87
Self-citationAmplification of RNA transcripts using terminal continuation
Che, S., & Ginsberg, S. D. (2003) · Laboratory Investigation · doi:10.1038/labinvest.3700005 · Cited by 85
Self-citationmRNA Expression Analysis of Tissue Sections and Single Cells
Eberwine, J. H., Kacharmina, J. E., Andrews, C., Miyashiro, K., McIntosh, T. K., Becker, K. G., Barrett, T., Hinkle, D., Dent, G. W., & Marciano, P. G. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-21-08310.2001 · Cited by 79
Boissière‐Michot, F., Faucheux, B. A., Ruberg, M., Agid, Y., & Hirsch, É. C. (1997) · Experimental Neurology · doi:10.1006/exnr.1997.6443 · Cited by 79
Lacalle, S. D., Cooper, J. D., Svendsen, C. N., Dunnett, S. B., & Sofroniew, M. V. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00239-4 · Cited by 76
Chu, Y., Cochran, E. J., Bennett, D. A., Mufson, E. J., & Kordower, J. H. (2001) · The Journal of Comparative Neurology · doi:10.1002/cne.1284 · Cited by 69
Self-citationRNA Amplification in Brain Tissues
Ginsberg, S. D., & Che, S. (2002) · Neurochemical Research · doi:10.1023/a:1020944502581 · Cited by 66
Self-citationGinsberg, S. D., & Che, S. (2005) · The Journal of Comparative Neurology · doi:10.1002/cne.20535 · Cited by 62
Self-citationGinsberg, S. D., & Che, S. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700110 · Cited by 61
Self-citationCounts, S., Chen, E., Che, S., Ikonomović, M. D., Wuu, J., Ginsberg, S. D., DeKosky, S. T., & Mufson, E. J. (2006) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000090906 · Cited by 52
Self-citationExpression profiling in the aging brain: A perspective
Galvin, J. E., & Ginsberg, S. D. (2005) · Ageing Research Reviews · doi:10.1016/j.arr.2005.06.009 · Cited by 34
Self-citationSaragovi, H. U. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03479.x · Cited by 22
Expression profiling and pharmacotherapeutic development in the central nervous system.
Galvin, J. E., & Ginsberg, S. D. (2004) · PubMed · Cited by 20
Self-citation
Cited by
Brain-derived neurotrophic factor in neurodegenerative diseases
Zuccato, C., & Cattaneo, E. (2009) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.54 · Cited by 947
Alzheimer's Disease: From Pathology to Therapeutic Approaches
Jakob‐Roetne, R., & Jacobsen, H. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200802808 · Cited by 626
Cholinergic system during the progression of Alzheimer’s disease: therapeutic implications
Mufson, E. J., Counts, S. E., Perez, S. E., & Ginsberg, S. D. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.11.1703 · Cited by 587
Self-citationThe significance of the cholinergic system in the brain during aging and in Alzheimer’s disease
Schliebs, R., & Arendt, T. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0579-2 · Cited by 530
Neurotrophic factors in Alzheimer’s disease: role of axonal transport
Schindowski, K., Belarbi, K., & Buée, L. (2008) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2007.00378.x · Cited by 335
Metadata
- Authors
- Ginsberg, S. D., Che, S., Wuu, J., Counts, S. E., & Mufson, E. J.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2006-03-15
- Volume
- 97
- Issue
- 2
- Pages
- 475-487
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1494415215
- Cited by
- 255
- References
- 65
- FWCI
- 9.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.